Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34


Illumination of cell cycle progression by multi-fluorescent sensing system.

Liu S, Li J, Wang T, Xu J, Liu Z, Wang H, Wei GH, Ianni A, Braun T, Yue S.

Cell Cycle. 2019 Jun;18(12):1364-1378. doi: 10.1080/15384101.2019.1618117. Epub 2019 May 26.


Association between homocysteine, vitamin B 12 , folic acid and erectile dysfunction: a cross-sectional study in China.

Chen Y, Li J, Li T, Long J, Liao J, Wei GH, Mo Z, Cheng J.

BMJ Open. 2019 May 22;9(5):e023003. doi: 10.1136/bmjopen-2018-023003.


The Role of HOX Transcription Factors in Cancer Predisposition and Progression.

Li B, Huang Q, Wei GH.

Cancers (Basel). 2019 Apr 12;11(4). pii: E528. doi: 10.3390/cancers11040528. Review.


Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness.

Xia JH, Wei GH.

Mol Cell Oncol. 2018 Sep 20;5(6):e1516451. doi: 10.1080/23723556.2018.1516451. eCollection 2018.


Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Sipeky C, Gao P, Zhang Q, Wang L, Ettala O, Talala KM, Tammela TLJ, Auvinen A, Wiklund F, Wei GH, Schleutker J.

Clin Cancer Res. 2018 Dec 15;24(24):6265-6276. doi: 10.1158/1078-0432.CCR-18-0444. Epub 2018 Sep 4.


ANO7 is associated with aggressive prostate cancer.

Kaikkonen E, Rantapero T, Zhang Q, Taimen P, Laitinen V, Kallajoki M, Jambulingam D, Ettala O, Knaapila J, Boström PJ, Wahlström G, Sipeky C, Pursiheimo JP, Tammela T, Kellokumpu-Lehtinen PL; PRACTICAL Consortium, Fey V, Maehle L, Wiklund F, Wei GH, Schleutker J.

Int J Cancer. 2018 Nov 15;143(10):2479-2487. doi: 10.1002/ijc.31746. Epub 2018 Sep 22.


Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis.

Skarp S, Kämäräinen OP, Wei GH, Jakkula E, Kiviranta I, Kröger H, Auvinen J, Lehenkari P, Ala-Kokko L, Männikkö M.

PLoS One. 2018 Aug 29;13(8):e0203313. doi: 10.1371/journal.pone.0203313. eCollection 2018.


Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium, Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH.

Cell. 2018 Jul 26;174(3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. Epub 2018 Jul 19.


High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.

Zhang P, Xia JH, Zhu J, Gao P, Tian YJ, Du M, Guo YC, Suleman S, Zhang Q, Kohli M, Tillmans LS, Thibodeau SN, French AJ, Cerhan JR, Wang LD, Wei GH, Wang L.

Nat Commun. 2018 May 22;9(1):2022. doi: 10.1038/s41467-018-04451-x.


A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer.

Zhang B, Chen MY, Shen YJ, Zhuo XB, Gao P, Zhou FS, Liang B, Zu J, Zhang Q, Suleman S, Xu YH, Xu MG, Xu JK, Liu CC, Giannareas N, Xia JH, Zhao Y, Huang ZL, Yang Z, Cheng HD, Li N, Hong YY, Li W, Zhang MJ, Yu KD, Li G, Sun MH, Chen ZD, Wei GH, Shao ZM.

Cancer Res. 2018 Jun 1;78(11):3087-3097. doi: 10.1158/0008-5472.CAN-17-1721. Epub 2018 Mar 23.


Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.

Suleman S, Wei GH.

Asian J Urol. 2017 Oct;4(4):199-200. doi: 10.1016/j.ajur.2017.04.003. Epub 2017 May 10. No abstract available.


Ataxin-10 is involved in Golgi membrane dynamics.

Tian J, Shi Y, Nai S, Geng Q, Zhang L, Wei GH, Xu X, Li J.

J Genet Genomics. 2017 Nov 20;44(11):549-552. doi: 10.1016/j.jgg.2017.11.002. Epub 2017 Nov 11. No abstract available.


Systematic identification of regulatory variants associated with cancer risk.

Liu S, Liu Y, Zhang Q, Wu J, Liang J, Yu S, Wei GH, White KP, Wang X.

Genome Biol. 2017 Oct 23;18(1):194. doi: 10.1186/s13059-017-1322-z.


Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.

Ren S, Wei GH, Liu D, Wang L, Hou Y, Zhu S, Peng L, Zhang Q, Cheng Y, Su H, Zhou X, Zhang J, Li F, Zheng H, Zhao Z, Yin C, He Z, Gao X, Zhau HE, Chu CY, Wu JB, Collins C, Volik SV, Bell R, Huang J, Wu K, Xu D, Ye D, Yu Y, Zhu L, Qiao M, Lee HM, Yang Y, Zhu Y, Shi X, Chen R, Wang Y, Xu W, Cheng Y, Xu C, Gao X, Zhou T, Yang B, Hou J, Liu L, Zhang Z, Zhu Y, Qin C, Shao P, Pang J, Chung LWK, Xu J, Wu CL, Zhong W, Xu X, Li Y, Zhang X, Wang J, Yang H, Wang J, Huang H, Sun Y.

Eur Urol. 2017 Sep 18. pii: S0302-2838(17)30720-0. doi: 10.1016/j.eururo.2017.08.027. [Epub ahead of print]


Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project.

Chen Y, Li J, Hu Y, Zhang H, Yang X, Jiang Y, Yao Z, Chen Y, Gao Y, Tan A, Liao M, Lu Z, Wu C, Xian X, Wei S, Zhang Z, Chen W, Wei GH, Wang Q, Mo Z.

Sci Rep. 2017 Aug 22;7(1):9143. doi: 10.1038/s41598-017-09751-8.


Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Chen Y, Zhang Q, Wang Q, Li J, Sipeky C, Xia J, Gao P, Hu Y, Zhang H, Yang X, Chen H, Jiang Y, Yang Y, Yao Z, Chen Y, Gao Y, Tan A, Liao M, Schleutker J, Xu J, Sun Y, Wei GH, Mo Z.

Sci Rep. 2017 Jul 3;7(1):4538. doi: 10.1038/s41598-017-04731-4.


Genomic Insight into the Role of lncRNA in Cancer Susceptibility.

Gao P, Wei GH.

Int J Mol Sci. 2017 Jun 9;18(6). pii: E1239. doi: 10.3390/ijms18061239. Review.


SIRT1 deacetylates the cardiac transcription factor Nkx2.5 and inhibits its transcriptional activity.

Tang X, Ma H, Han L, Zheng W, Lu YB, Chen XF, Liang ST, Wei GH, Zhang ZQ, Chen HZ, Liu DP.

Sci Rep. 2016 Nov 7;6:36576. doi: 10.1038/srep36576.


Structural basis for DNA recognition by STAT6.

Li J, Rodriguez JP, Niu F, Pu M, Wang J, Hung LW, Shao Q, Zhu Y, Ding W, Liu Y, Da Y, Yao Z, Yang J, Zhao Y, Wei GH, Cheng G, Liu ZJ, Ouyang S.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13015-13020. Epub 2016 Nov 1.


Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.

Zhang K, Lee HM, Wei GH, Manninen A.

Oncotarget. 2016 Dec 20;7(51):84178-84189. doi: 10.18632/oncotarget.12390.

Supplemental Content

Loading ...
Support Center